Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF – Get Free Report) shares dropped 4.3% during mid-day trading on Monday . The stock traded as low as $28.71 and last traded at $28.71. Approximately 226 shares changed hands during mid-day trading, an increase of 3% from the average daily volume of 220 shares. The stock had previously closed at $29.99.
Analyst Ratings Changes
Separately, Barclays raised Swedish Orphan Biovitrum AB (publ) to a “strong-buy” rating in a research note on Wednesday, January 8th.
Check Out Our Latest Stock Report on Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ) Stock Performance
About Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia. It offers Alprolix for haemophilia B; Aspaveli®/Empaveli for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); VONJO for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis; Zynlonta, an aggressive malignant disease; Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still’s disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection.
Further Reading
- Five stocks we like better than Swedish Orphan Biovitrum AB (publ)
- Where Do I Find 52-Week Highs and Lows?
- Can TikTok Stock Picks Really Make You Rich?
- Why Are Stock Sectors Important to Successful Investing?
- The “Quality” Rotation: Back to Basics Investing
- How to Find Undervalued Stocks
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Swedish Orphan Biovitrum AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swedish Orphan Biovitrum AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.